POTELIGEO

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 42747-761
  • Package NDC 42747-761-01
  • Application number BLA761051
  • SPL ID 1f51b7aa-6109-469c-b237-edfc3ee7b2b5
  • SPL set ID e53960ab-42a1-40d1-9c7d-eb013fe7f18f
  • UNII YI437801BE
  • RxCUI 2054081
  • RxCUI 2054086

What the source publishes

Labeler
Kyowa Kirin, Inc.
Active ingredients
mogamulizumab-kpkc
Form
INJECTION
Routes
INTRAVENOUS
Administrative status
present-in-source-snapshot
Marketing status
BLA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:42747-761_1f51b7aa-6109-469c-b237-edfc3ee7b2b5
{
  "name": "POTELIGEO",
  "splId": "1f51b7aa-6109-469c-b237-edfc3ee7b2b5",
  "labels": [
    {
      "setId": "e53960ab-42a1-40d1-9c7d-eb013fe7f18f",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e53960ab-42a1-40d1-9c7d-eb013fe7f18f",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e53960ab-42a1-40d1-9c7d-eb013fe7f18f"
    }
  ],
  "routes": [
    "INTRAVENOUS"
  ],
  "labeler": "Kyowa Kirin, Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 VIAL, GLASS in 1 CARTON (42747-761-01)  / 5 mL in 1 VIAL, GLASS",
      "package_ndc": "42747-761-01",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20180808"
    }
  ],
  "productId": "42747-761_1f51b7aa-6109-469c-b237-edfc3ee7b2b5",
  "useDomain": "unknown",
  "dosageForm": "INJECTION",
  "productNdc": "42747-761",
  "deaSchedule": null,
  "genericName": "mogamulizumab-kpkc",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "MOGAMULIZUMAB",
      "strength": "4 mg/mL"
    }
  ],
  "applicationNumber": "BLA761051",
  "marketingCategory": "BLA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20180808",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000193866",
      "N0000193863",
      "N0000193867",
      "M0001357"
    ],
    "unii": [
      "YI437801BE"
    ],
    "rxcui": [
      "2054081",
      "2054086"
    ],
    "spl_set_id": [
      "e53960ab-42a1-40d1-9c7d-eb013fe7f18f"
    ],
    "pharm_class_cs": [
      "Antibodies, Monoclonal [CS]"
    ],
    "pharm_class_epc": [
      "Chemokine Receptor Type 4 Interaction [EPC]",
      "Monoclonal Antibody [EPC]"
    ],
    "pharm_class_moa": [
      "Chemokine Receptor Type 4 Interactions [MoA]"
    ],
    "manufacturer_name": [
      "Kyowa Kirin, Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:42747-761_1f51b7aa-6109-469c-b237-edfc3ee7b2b5"